There is a large amount of evidence on laboratory and clinical characteristics of vitamin K antagonists. A growing body of evidence is becoming available on the first new oral anticoagulant drugs available for clinical use, dabigatran and rivaroxaban.
University of Insubria, Varese, Italy. walter.ageno [at] uninsubria.it
Chest. 2012 Feb;141(2 Suppl):e44S-88S
© Galenicom 1999-2013